Literature DB >> 25825230

Choroidal involvement in Rosai-Dorfman syndrome may be depicted and followed using enhanced depth imaging optical coherence tomography (EDI-OCT).

Timothy William Isaacs1, Tersia L Vermeulen2, Dominic Spagnolo3, Ben Amanuel3.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25825230     DOI： 10.1007/s00417-015-2988-0

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN： 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  6 in total

1.  Choroidal involvement in Rosai-Dorfman syndrome may be depicted and followed using enhanced depth imaging optical coherence tomography (EDI-OCT).

Authors:  Janelle Fassbender; Shlomit Schaal
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-03-20       Impact factor: 3.117

2.  Disseminated sinus histiocytosis with massive lymphadenopathy: its pathologic aspects.

Authors:  J J Buchino; R P Byrd; D R Kmetz
Journal:  Arch Pathol Lab Med       Date:  1982-01       Impact factor: 5.534

Review 3.  Bilateral anterior granulomatous uveitis associated with cutaneous Rosai-Dorfman disease.

Authors:  Juan G Gaviria; Daniel A Johnson; Marsha C Kinney; Liana H Proffer; Jacqueline M Losi-Sasaki; Eric W Kraus
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-09-30       Impact factor: 3.117

4.  Rosai-dorfman disease diagnosed because of bilateral choroidal masses.

Authors:  Yoreh Barak; Melissa G Tong; Todd J Purkiss; Shlomit Schaal
Journal:  Retin Cases Brief Rep       Date:  2012

Review 5.  Rosai-Dorfman disease presenting as choroidal melanoma: a case report and review of the literature.

Authors:  Tersia L Vermeulen; Timothy W Isaacs; Dominic Spagnolo; Benhur Amanuel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-10-24       Impact factor: 3.117

Review 6.  Enhanced depth imaging optical coherence tomography of intraocular tumors: from placid to seasick to rock and rolling topography--the 2013 Francesco Orzalesi Lecture.

Authors:  Carol L Shields; Marco Pellegrini; Sandor R Ferenczy; Jerry A Shields
Journal:  Retina       Date:  2014-08       Impact factor: 4.256
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.